Canary Speech, the leading AI-powered voice biomarker health tech company, today announced the appointment of Kang Hsu, Jr., MD as its new Chief Medical Officer (CMO). Dr. Hsu joins the executive leadership team with more than two decades of clinical, operational, and digital health experience. He will lead the company’s medical strategy, clinical innovation, and help position Canary Speech as the leader in vocal biomarker technology.
Add Comment